Difference between revisions of "Prostate imaging reporting and data system"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
'''Prostate imaging reporting and data system''', commonly known by the abbreviation '''PI-RADS''', a standardized system for reporting prostate radiology.<ref>{{Cite journal | last1 = Fütterer | first1 = JJ. | last2 = Moche | first2 = M. | last3 = Busse | first3 = H. | last4 = Yakar | first4 = D. | title = In-Bore MR-Guided Biopsy Systems and Utility of PI-RADS. | journal = Top Magn Reson Imaging | volume = | issue = | pages = | month = May | year = 2016 | doi = 10.1097/RMR.0000000000000090 | PMID = 27187168 }}</ref> | '''Prostate imaging reporting and data system''', commonly known by the abbreviation '''PI-RADS''', a standardized system for reporting prostate radiology.<ref>{{Cite journal | last1 = Fütterer | first1 = JJ. | last2 = Moche | first2 = M. | last3 = Busse | first3 = H. | last4 = Yakar | first4 = D. | title = In-Bore MR-Guided Biopsy Systems and Utility of PI-RADS. | journal = Top Magn Reson Imaging | volume = | issue = | pages = | month = May | year = 2016 | doi = 10.1097/RMR.0000000000000090 | PMID = 27187168 }}</ref> | ||
==Scoring and meaning== | |||
{| class="wikitable sortable" | |||
! PI-RADS score | |||
! Meaning | |||
|- | |||
| 1 | |||
| very low probability of significant cancer | |||
|- | |||
| 2 | |||
| low probability of significant cancer | |||
|- | |||
| 4 | |||
| intermediate probability of significant cancer | |||
|- | |||
| 4 | |||
| high probability of significant cancer | |||
|- | |||
| 5 | |||
| very high probability of significant cancer | |||
|} | |||
==See also== | ==See also== | ||
Revision as of 16:48, 22 May 2016
Prostate imaging reporting and data system, commonly known by the abbreviation PI-RADS, a standardized system for reporting prostate radiology.[1]
Scoring and meaning
| PI-RADS score | Meaning |
|---|---|
| 1 | very low probability of significant cancer |
| 2 | low probability of significant cancer |
| 4 | intermediate probability of significant cancer |
| 4 | high probability of significant cancer |
| 5 | very high probability of significant cancer |
See also
References
- ↑ Fütterer, JJ.; Moche, M.; Busse, H.; Yakar, D. (May 2016). "In-Bore MR-Guided Biopsy Systems and Utility of PI-RADS.". Top Magn Reson Imaging. doi:10.1097/RMR.0000000000000090. PMID 27187168.